These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1198248)

  • 41. [Use of non-approved drugs].
    Rygnestad T
    Tidsskr Nor Laegeforen; 1998 Feb; 118(6):932-3. PubMed ID: 9543810
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug policy in Slovakia and its reflection in prescriptions. 1. Prescriptions for mass-produced drugs according to physician specialty].
    Springer V; Kisska I; Hrcková M
    Ceska Slov Farm; 2002 May; 51(3):129-33. PubMed ID: 12058353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Distribution safety of common pharmaceuticals. A question to Laegemiddelstyrelsen and to Nycomed].
    Dittmann LE
    Ugeskr Laeger; 1999 Mar; 161(10):1430-1. PubMed ID: 10085756
    [No Abstract]   [Full Text] [Related]  

  • 44. [Control of prescriptions for dangerous drugs at MOH level in the County of Aalborg during a period of approximately ten years].
    Jacobsen M
    Ugeskr Laeger; 1971 Oct; 133(40):1981-7. PubMed ID: 5124226
    [No Abstract]   [Full Text] [Related]  

  • 45. [Consumption of prescription drugs in 60-65 years old population in Mexico. National Survey on Addictions, 1993].
    Tapia-Conyer R; Cravioto P; Borges-Yáñez SA; de la Rosa B
    Salud Publica Mex; 1996; 38(6):458-65. PubMed ID: 9054015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Considerations in the production and control of virus vaccines.
    Gray A
    Bull Parenter Drug Assoc; 1971; 25(4):175-84. PubMed ID: 5123218
    [No Abstract]   [Full Text] [Related]  

  • 47. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 48. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

  • 49. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 50. ["The safety of drugs a stepchild of medicine". Calcium blockers not the only example].
    Karlsson Y
    Lakartidningen; 1996 Oct; 93(43):3804-6. PubMed ID: 8965557
    [No Abstract]   [Full Text] [Related]  

  • 51. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 52. [Drugs after 1992; a comparison with yet many unknowns].
    Boer EJ
    Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1863-7. PubMed ID: 2215761
    [No Abstract]   [Full Text] [Related]  

  • 53. Computerizing cuts prescribing of psychotropics.
    Med World News; 1978 Sep; 19(18):11-2. PubMed ID: 10316683
    [No Abstract]   [Full Text] [Related]  

  • 54. [Drug registration in the county of Jämtland: Clinical experiences of the preliminary study in 1968].
    Bergström I; Carmstad A; Elwin CE; Heedman PA; Källström B; Westerholm B; Wiman F
    Lakartidningen; 1970 Jun; 67():Suppl III:91+. PubMed ID: 5478701
    [No Abstract]   [Full Text] [Related]  

  • 55. [Drugs--their synthesis and their control by the manufacturer and by the government].
    Wüst F
    Z Krankenpfl; 1972 May; 65(5):177-81. PubMed ID: 4482788
    [No Abstract]   [Full Text] [Related]  

  • 56. [Strategies for the use and consumption of antibiotics].
    Pérez Gorricho B; Baquero F
    Med Clin (Barc); 1986 Apr; 86(13):547-9. PubMed ID: 3713332
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drugs and instructions to the consumer].
    Andersen AH
    Ugeskr Laeger; 1973 Aug; 135(32):1698-700. PubMed ID: 4773381
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug and alcohol policy at the global level.
    Anderson P
    Drug Alcohol Rev; 2006 Nov; 25(6):485-7. PubMed ID: 17132568
    [No Abstract]   [Full Text] [Related]  

  • 60. [Developments by pharmaceutical companies].
    Orthel FW
    Tijdschr Diergeneeskd; 2001 Feb; 126(3):76-84. PubMed ID: 11227404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.